Biothera Files Patent Suit, Wins IFT Innovation Award

EAGAN, Minn.—Biothera and the Massachusetts Institute of Technology (MIT) filed a patent infringement lawsuit in U.S. District Court, Northern District of Illinois, against Biorgin, alleging the Brazilian company sold beta 1,3/1,6 gluco polysaccharide ingredients in the United States in violation of patents owned by MIT and licensed to Biothera. The plaintiffs are seeking a permanent injunction and unspecified damages.

In additional news, Biothera’s Wellmune WGP, an immune-enhancing functional food and beverage ingredient, received a 2007 Innovation Award from the Institute of Food Technologists (IFT). Wellmune WGP was one of six award recipients selected by a panel of experts from industry, academia and government. “We are honored to be selected from so many outstanding and innovative food ingredients,” said Richard G. Mueller, president and CEO, Biothera (www.BiotheraPharma.com). “We believe this award reflects the significant technology investment in Wellmune WGP as well as its potential to become the premier immune enhancement ingredient in the food and beverage industry.”

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines